Sean Morrison
16Patents
5h-index
13Co-inventors
63Inventor score
Filing activity: Oct 22, 1999 → May 1, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6984522B2 | Isolation and use of solid tumor stem cells | Chemistry; Metallurgy | 90 | Expired |
| US7115360B2 | Isolation and use of solid tumor stem cells | Chemistry; Metallurgy | 68 | Expired |
| US7850961B2 | Methods for targeting solid tumor stem cells in a solid tumor using a notch4 receptor antagonist | Chemistry; Metallurgy | 22 | Active |
| US7713710B2 | Isolation and use of solid tumor stem cells | Chemistry; Metallurgy | 20 | Active |
| US7510877B2 | Hematopoietic stem cell identification and isolation | Chemistry; Metallurgy | 15 | Expired |
| US6759242B1 | Low oxygen culturing of neural crest stem cells and methods of use | Chemistry; Metallurgy | 5 | Expired |
| US8383404B2 | Hematopoietic stem cell identification and isolation | Chemistry; Metallurgy | 2 | Active |
| US11285190B2 | CLEC11a is a bone growth agent | Human Necessities | 1 | Active |
| US9572828B2 | Treatment for melanoma | Human Necessities | 0 | Active |
| US8357491B2 | Isolation and use of solid tumor stem cells | Chemistry; Metallurgy | 0 | Active |
| US9492538B2 | Isolation and use of solid tumor stem cells | Chemistry; Metallurgy | 0 | Active |
| US9561245B2 | Combination treatments for melanoma | Human Necessities | 0 | Active |
| US11890320B2 | CLEC11A is a bone growth agent | Human Necessities | 0 | Active |
| US10227567B2 | Isolation and use of solid tumor stem cells | Chemistry; Metallurgy | 0 | Active |
| US8043853B2 | Postnatal gut neural crest stem cells | Chemistry; Metallurgy | 0 | Active |
| US7919316B2 | Hematopoietic stem cell identification and isolation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.